IL107003A0 - 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man - Google Patents

3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man

Info

Publication number
IL107003A0
IL107003A0 IL107003A IL10700393A IL107003A0 IL 107003 A0 IL107003 A0 IL 107003A0 IL 107003 A IL107003 A IL 107003A IL 10700393 A IL10700393 A IL 10700393A IL 107003 A0 IL107003 A0 IL 107003A0
Authority
IL
Israel
Prior art keywords
pyrrolo
disubstituted
dihydro
heterocyclic
man
Prior art date
Application number
IL107003A
Other languages
English (en)
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL107003A0 publication Critical patent/IL107003A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL107003A 1992-09-18 1993-09-14 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man IL107003A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/947,152 US5278162A (en) 1992-09-18 1992-09-18 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man

Publications (1)

Publication Number Publication Date
IL107003A0 true IL107003A0 (en) 1993-12-28

Family

ID=25485622

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107003A IL107003A0 (en) 1992-09-18 1993-09-14 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man

Country Status (10)

Country Link
US (1) US5278162A (ja)
EP (1) EP0660833A1 (ja)
JP (1) JPH08501550A (ja)
CN (1) CN1094406A (ja)
AU (1) AU4856893A (ja)
CA (1) CA2144636A1 (ja)
IL (1) IL107003A0 (ja)
TW (1) TW248560B (ja)
WO (1) WO1994006793A1 (ja)
ZA (1) ZA936872B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
ATE271553T1 (de) * 1994-04-29 2004-08-15 Pfizer Neue cyclische und acyclische amide zur erhöhung der neurotransmitter ausschüttung
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
AR053710A1 (es) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
MY158766A (en) * 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053713A1 (es) * 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
MX2009003874A (es) * 2006-10-12 2009-04-22 Xenon Pharmaceuticals Inc Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos.
JP5460324B2 (ja) * 2006-10-12 2014-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド 治療剤としてのスピロ−オキシインドール化合物の使用
TW200825091A (en) * 2006-10-12 2008-06-16 Xenon Pharmaceuticals Inc Spiro-oxindole compounds useful in treating sodium channel-mediated diseases or conditions
RU2011119626A (ru) 2008-10-17 2012-11-27 Ксенон Фармасьютикалз Инк. Спирооксиндольные соединения и их применение в качестве терапевтичеких средств
CA2741024A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
MY165579A (en) * 2009-10-14 2018-04-05 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
US9504671B2 (en) 2010-02-26 2016-11-29 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
EP0419561A1 (en) * 1988-06-14 1991-04-03 Schering Corporation Heterobicyclic compounds having antiinflammatory activity
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
EP0660833A1 (en) 1995-07-05
CN1094406A (zh) 1994-11-02
CA2144636A1 (en) 1994-03-31
WO1994006793A1 (en) 1994-03-31
TW248560B (ja) 1995-06-01
AU4856893A (en) 1994-04-12
ZA936872B (en) 1995-03-17
JPH08501550A (ja) 1996-02-20
US5278162A (en) 1994-01-11

Similar Documents

Publication Publication Date Title
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
IL107003A0 (en) 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man
GB9301342D0 (en) Child's safety device
ZA904991B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)-diazepin-6-ones and-thiones and their use for the treatment of aids
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
GB9203039D0 (en) Treatment
ZA935154B (en) Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions
GB9309743D0 (en) Child's safety device
GB9201920D0 (en) Novel treatment i
ZA931063B (en) Treatment of glaucoma.
EP0557949A3 (en) Process for the preparation of 2,4,5 trifluorobenzonitrile
GB9222985D0 (en) Use of the tarchonanthus camphoratus
PH27414A (en) 1,2,4-oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents
GB9214373D0 (en) Newadjustable "photo-back"
GB2282529B (en) Baby's bath
GB9203637D0 (en) Novel treatment
ZA936874B (en) Process for the preparation of 5,6-diacetoxyindole
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
ZA937604B (en) 3,3-disubstituted tri and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders
GB9607420D0 (en) Formulations of mannose phosphates useful in the treatment of fibrotic disorders
GB9225859D0 (en) Novel treatment
IL100629A0 (en) Apparatus for the treatment of papulosquamous disorders
GB9220588D0 (en) The "trailersafe"
GB9204036D0 (en) The"secura-grip"